Levofloxacin: all 151 studies that test it

Page 1 of 2. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.

• Fluoroquinolone-Doxycycline Oral Treatments for Adults With Uncomplicated BrucellosisNot yet recruitingNCT07887126Not applicable
• Intracameral Levofloxacin Versus Moxifloxacin After Cataract SurgeryNot yet recruitingNCT07850414Not applicable
• Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired PneumoniaNot yet recruitingNCT07843017Phase 2/3
• Efficacy & Safety of Fluoroquinolone-Based Brucellosis Regimens (BRUCE)Not yet recruitingNCT07779629Not applicable
• Rationale of Subcutaneous Levofloxacin Infiltration as an Adjunct for Surgical Site Infection Prevention in Emergency LaparotomyNot yet recruitingNCT07696819Not applicable
• Vonoprazan High-Dose Dual VS Levofloxacin ConcomitantNot yet recruitingNCT07624422Phase 4
• Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)Not yet recruitingNCT07528417Phase 2
• Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori InfectionNot yet recruitingNCT07040839Phase 4
• Comparison of Two Treatment Regimens of Helicobacter Pylori InfectionNot yet recruitingNCT07021729Phase 4
• A Study Comparing Doxycycline and Levofloxacin for Treating COPD ExacerbationsNot yet recruitingNCT06915688Not applicable
• Local Antibiotic Delivery for Community Acquired PneumoniaNot yet recruitingNCT06859450Phase 2/3
• Intralesional Injection of Levofloxacin for the Management of Cutaneous LeishmaniasisRecruitingNCT06797544Phase 2
• Retrograde Intrarenal Surgery Low Risk TrialEnrolling by invitationNCT06741917Phase 4
• Shorter and Safer Treatment Regimens for Latent TBRecruitingNCT06498414Phase 2/3
• Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAPRecruitingNCT06494072Phase 4
• Safety and Efficacy of Levofloxacin for Acute Ischemic StrokeRecruitingNCT05799326Not applicable
• Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic StrokeNot yet recruitingNCT05743101Not applicable
• Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic StrokeRecruitingNCT05741905Not applicable
• Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective EndocarditisRecruitingNCT05398679Phase 4
• Absorption of Antibiotics With High Oral Bioavailability in Short-bowel SyndromeRecruitingNCT05302531Phase 1
• Helicobacter Pylori Eradication and Follow-upRecruitingNCT05061732Phase 4
• Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI PreventionCompletedNCT06017479Phase 1/2Results posted
• Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)TerminatedNCT05156437Phase 4Results posted
• Early Antibiotics After Aspiration in ICU PatientsTerminatedNCT05079620Phase 4Results posted
• Ciprofloxacin Versus Levofloxacin in Stem Cell TransplantCompletedNCT03850379Phase 2Results posted
• Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract SurgeryCompletedNCT03740659Phase 2Results posted
• Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)TerminatedNCT03697993Phase 4Results posted
• Topical Antibiotics in Chronic RhinosinusitisCompletedNCT03673956Phase 1/2Results posted
• Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy SubjectsCompletedNCT03519516Phase 1Results posted
• Healthy Patients & Effect of AntibioticsCompletedNCT03098485Not applicableResults posted
• Treatment Shortening of MDR-TB Using Existing and New DrugsCompletedNCT02619994Phase 2Results posted
• The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT02409290Phase 3Results posted
• Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary SarcoidosisCompletedNCT02024555Phase 2Results posted
• Oral Versus Topical Antibiotics for Chronic Rhinosinusitis ExacerbationsCompletedNCT01988779Phase 3Results posted
• Efficacy and Safety of Levofloxacin for the Treatment of MDR-TBCompletedNCT01918397Phase 2Results posted
• Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial PneumoniaCompletedNCT01524302Phase 4Results posted
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell TransplantationCompletedNCT01371656Phase 3Results posted
• Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot StudyCompletedNCT01353339Phase 4Results posted
• BK Treatment StudyCompletedNCT01034176Phase 4Results posted
• An Effectiveness and Safety Study for Levofloxacin in Chronic ProstatitisCompletedNCT00402688Phase 3Results posted
• Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisCompletedNCT00396084Phase 1/2Results posted
• Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic ApproachTerminatedNCT00250718Phase 2Results posted
• Levofloxacin Pharmacokinetics (PK) in the Severely ObeseCompletedNCT00176306Phase 4Results posted
• Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction PhaseTerminatedNCT07320534Phase 4
• Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid FeverCompletedNCT07150065Phase 2
• Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of EmpyemaCompletedNCT06787885Not applicable
• Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortActive, not recruitingNCT06649721Phase 3
• Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter PyloriCompletedNCT06414707Phase 3
• Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial OsteomyelitisStatus unknownNCT05867654Phase 4
• Eradication of H. Pylori Infection With MoxifloxacinCompletedNCT05863858Phase 3
• One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIALStatus unknownNCT05728424Phase 3
• Bioequivalence Study of Levomerc 500 mg TabletsCompletedNCT05339295Phase 1
• Susceptibility-Guided Therapy for Helicobacter Pylori Infection TreatmentWithdrawnNCT05250050Phase 4
• Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to PenicillinStatus unknownNCT05129176Phase 4
• Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic PatientsStatus unknownNCT05023577Phase 4
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori InfectionStatus unknownNCT04991584Not applicable
• Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated TuberculosisActive, not recruitingNCT04951986Phase 3
• Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and DysglycemiaCompletedNCT04456712Phase 4
• Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer DiseaseStatus unknownNCT04432233Phase 4
• Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous NephrolithotomyStatus unknownNCT04374188Not applicable
• The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%Status unknownNCT04214821Phase 1/2
• The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%Status unknownNCT04212429Phase 1/2
• Helicobacter Pylori First-line Treatment in Patients Allergic to PenicillinStatus unknownNCT04122287Phase 4
• Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.Status unknownNCT04107194Phase 3
• Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.Status unknownNCT04090021Phase 4
• Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin SolutionCompletedNCT03832465Phase 4
• Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TBActive, not recruitingNCT03828201Phase 2
• Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin AllergyCompletedNCT03708848Phase 4
• Short Compared With Standard Duration of Antibiotic Treatment for AECOPDCompletedNCT03698682Phase 2
• Efficiency of Antibacterial Prophylaxis in Azacitidine Treated PatientsCompletedNCT03594149Phase 3
• Genotypic Resistance Guided Therapy for Refractory H. Pylori InfectionStatus unknownNCT03555526Phase 4
• Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
• Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal PolyposisStatus unknownNCT03472144Phase 3
• Tailored Therapy for Helicobacter Pylori Rescue TreatmentCompletedNCT03413020Phase 4
• Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous NephrolithotomyStatus unknownNCT03178292Not applicable
• Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract InfectionsStatus unknownNCT03160807Phase 4
• Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori TreatmentStatus unknownNCT03139253Phase 4
• Antibiotics to Decrease Post ERCP CholangitisStatus unknownNCT03087656Phase 4
• Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?Status unknownNCT03038321Phase 4
• Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS PatientsCompletedNCT02981615Phase 3
• Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and LevofloxacinWithdrawnNCT02975570Phase 3
• Optimizing Treatment to Improve TBM Outcomes in ChildrenCompletedNCT02958709Phase 1/2
• Tailored Versus Empiric Therapy for Helicobacter Pylori TreatmentCompletedNCT02935010Phase 4
• Shortened Regimens for Drug-susceptible Pulmonary TuberculosisStatus unknownNCT02901288Phase 4
• Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi ArabiaCompletedNCT02884713Not applicable
• The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract LithotomyStatus unknownNCT02789579Early Phase 1
• Efficiency Study of Aspirin to Prevent the Occurrence of Prostate CancerStatus unknownNCT02757365Phase 4
• Evaluating Newly Approved Drugs for Multidrug-resistant TBCompletedNCT02754765Phase 3
• Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible StaphylococcusCompletedNCT02701608Phase 3
• Population Pharmacokinetics and Pharmacodynamics Modeling to Optimize Dosage Regimen of LevofloxacinCompletedNCT02699658Phase 2
• Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. PyloriStatus unknownNCT02693574Phase 4
• A Two Week Nitazoxanidebased Quadruple RegimenStatus unknownNCT02621359Phase 3
• Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in OutpatientsStatus unknownNCT02600806Phase 4
• Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract SurgeryCompletedNCT02573610Phase 3
• Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic PatientsCompletedNCT02466919Phase 4
• An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant TuberculosisCompletedNCT02454205Phase 2/3
• Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell TransplantationStatus unknownNCT02148016Phase 1/2
• Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPDCompletedNCT02067780Phase 3
• Pharmacokinetics of Levofloxacin in Intensive Care UnitCompletedNCT02018081Phase 4
• Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.TerminatedNCT01875263Phase 3

← Levofloxacin overview